DEPOLIP Trademark

Trademark Overview

On Wednesday, June 30, 2010, a trademark application was filed for DEPOLIP with the United States Patent and Trademark Office. The USPTO has given the DEPOLIP trademark a serial number of 79085491. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, July 1, 2020. This trademark is owned by ETHYPHARM. The DEPOLIP trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical parenteral depot preparations for the medium and long term treatment and prevention of human and animal diseases in the nature of cancer, central nervous system disorder, hormonal disorder, metabolic disorder, immunologic disorder, cardiovascular system disorder, infection, pain, addiction, ophthalmological disorder, gynaecological disorder and dermatological disorder; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; sanitary preparations for medical use; all purpose disinfectants; reagent chemical, biochemical and biological preparation for the medium and long term treatment and prevention of human and animal diseases in the nature of cancer, central nervous system disorder, hormonal disorder, metabolic disorder, immunologic disorder, cardiovascular system disorder, infection, pain, addiction, ophthalmological disorder, gynaecological disorder, and dermatological disorder

Research and development in the field of pharmacology, particularly relating to formation of in vivo lipidic gel for the controlled release of an active principle
depolip

General Information

Serial Number79085491
Word MarkDEPOLIP
Filing DateWednesday, June 30, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, July 1, 2020
Registration Number4120032
Registration DateTuesday, April 3, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2012

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Servicespharmaceutical parenteral depot preparations for the medium and long term treatment and prevention of human and animal diseases in the nature of cancer, central nervous system disorder, hormonal disorder, metabolic disorder, immunologic disorder, cardiovascular system disorder, infection, pain, addiction, ophthalmological disorder, gynaecological disorder and dermatological disorder; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; sanitary preparations for medical use; all purpose disinfectants; reagent chemical, biochemical and biological preparation for the medium and long term treatment and prevention of human and animal diseases in the nature of cancer, central nervous system disorder, hormonal disorder, metabolic disorder, immunologic disorder, cardiovascular system disorder, infection, pain, addiction, ophthalmological disorder, gynaecological disorder, and dermatological disorder
Goods and ServicesResearch and development in the field of pharmacology, particularly relating to formation of in vivo lipidic gel for the controlled release of an active principle
Pseudo MarkDEPO LIP

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 9, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameETHYPHARM
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameETHYPHARM
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameETHYPHARM
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Friday, January 15, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, January 15, 2021DEATH OF INTERNATIONAL REGISTRATION
Thursday, July 23, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, December 12, 2019NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 29, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Friday, November 8, 2019NEW REPRESENTATIVE AT IB RECEIVED
Sunday, August 4, 2019TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, August 3, 2019INVALIDATION PROCESSED
Tuesday, July 9, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, December 13, 2018NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 9, 2018CANCELLED SECTION 71
Monday, April 3, 2017COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sunday, April 21, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, October 30, 2012NOTIFICATION PROCESSED BY IB
Tuesday, October 30, 2012NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, July 5, 2012FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 5, 2012FINAL DISPOSITION PROCESSED
Tuesday, July 3, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 3, 2012REGISTERED-PRINCIPAL REGISTER
Wednesday, February 1, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 1, 2012NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, January 17, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2012PUBLISHED FOR OPPOSITION
Wednesday, December 28, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 28, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 28, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 10, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 2, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 2, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 2, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 18, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 18, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 18, 2011NON-FINAL ACTION E-MAILED
Wednesday, May 18, 2011NON-FINAL ACTION WRITTEN
Monday, May 16, 2011APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 11, 2011PAPER RECEIVED
Thursday, April 21, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 21, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 21, 2011ASSIGNED TO LIE
Sunday, April 17, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 9, 2010REFUSAL PROCESSED BY IB
Tuesday, October 19, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 19, 2010REFUSAL PROCESSED BY MPU
Tuesday, October 19, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 18, 2010NON-FINAL ACTION WRITTEN
Monday, October 11, 2010ASSIGNED TO EXAMINER
Tuesday, August 31, 2010APPLICATION FILING RECEIPT MAILED
Friday, August 27, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 26, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

depolip disorder system immunologic metabolic cardiovascular nervous hormonal infection gynaecological dermatological